Story thread · 2 reports / 2 sources
Sandoz shares up after $322 million biosimilar deal with Henlius
investing.com · 5h · first report
The coverage
- Sandoz targets industry patent void with $322m Henlius deal
finance.yahoo.com · 2h
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.